Campbell & Co. Investment Adviser »

Xeris Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $843k 104k 8.14
2025-06-30 $618k 132k 4.67

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Morgan Stanley
Qube Research & Technologies
Nuveen
Driehaus Capital Management
Rosalind Advisors
Goldman Sachs Group
Parkman Healthcare Partners
UBS Group
Connor, Clark & Lunn Investment Management
Renaissance Technologies

View all funds holding Xeris Pharmaceuticals